Inflammation Profiling of Critically Ill Coronavirus Disease 2019 Patients.

ABSTRACT:

Objectives

Coronavirus disease 2019 is caused by severe acute respiratory syndrome-coronavirus-2 infection to which there is no community immunity. Patients admitted to ICUs have high mortality, with only supportive therapies available. Our aim was to profile plasma inflammatory analytes to help understand the host response to coronavirus disease 2019.

Design

Daily blood inflammation profiling with immunoassays.

Setting

Tertiary care ICU and academic laboratory.

Subjects

All patients admitted to the ICU suspected of being infected with severe acute respiratory syndrome-coronavirus-2, using standardized hospital screening methodologies, had daily blood samples collected until either testing was confirmed negative on ICU day 3 (coronavirus disease 2019 negative),

SUBMITTER: Fraser DD 

PROVIDER: S-EPMC7314329 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature